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Abstract
Axon pathfinding is a subfield of neural development by which neurons send out axons to reach the correct targets. In
particular, motoneurons extend their axons toward skeletal muscles, leading to spontaneous motor activity. In this study,
we identified the zebrafish Ccdc80 and Ccdc80-like1 (Ccdc80-l1) proteins in silico on the basis of their high aminoacidic
sequence identity with the human CCDC80 (Coiled-Coil Domain Containing 80). We focused on ccdc80-l1 gene that is
expressed in nervous and non-nervous tissues, in particular in territories correlated with axonal migration, such as adaxial
cells and muscle pioneers. Loss of ccdc80-l1 in zebrafish embryos induced motility issues, although somitogenesis and
myogenesis were not impaired. Our results strongly suggest that ccdc80-l1 is involved in axon guidance of primary and
secondary motoneurons populations, but not in their proper formation. ccdc80-l1 has a differential role as regards the
development of ventral and dorsal motoneurons, and this is consistent with the asymmetric distribution of the transcript.
The axonal migration defects observed in ccdc80-l1 loss-of-function embryos are similar to the phenotype of several
mutants with altered Hedgehog activity. Indeed, we reported that ccdc80-l1 expression is positively regulated by the
Hedgehog pathway in adaxial cells and muscle pioneers. These findings strongly indicate ccdc80-l1 as a down-stream
effector of the Hedgehog pathway.
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Introduction
The development of a functional vertebrate nervous system
requires elaboration of a large number of diverse cell types. At
embryonic stages, the nervous system is a complex network of
growing axons, whose growth cones navigate in response to
guidance cues. Among them, motoneuron axons migrate toward
skeletal muscles, and form synaptic contacts [1]. Zebrafish
embryos exhibit spontaneous contractions of the musculature ever
since 18–19 hours post fertilization (hpf) when removed from their
protective chorion [2]. These movements are due to the early-
developing primary motoneurons (PMNs), that innervate the
myotome with nonoverlapping arbors. In zebrafish, PMNs are
present in each somitic hemisegment and are identified by their
specific axonal pathway and soma position within the spinal cord:
caudal primary motoneurons, middle primary motoneurons and
rostral primary motoneurons (CaPs, MiPs and RoPs, respectively)
[3,4,5]. PMNs extend their axons out of the spinal cord at about
16–17 hpf, following a common pathway: their growth cones
project ventrally along the medial surface of the myotome and
pause at the horizontal myoseptum, which separates dorsal and
ventral myotomes. Here, they specifically interact with muscle
pioneers [6,7], a subset of two to six cells for each somite early
differentiating into slow muscle fibers [8,9]. CaPs are responsible
for pioneering the common pathway before projecting the axons
that innervate the ventral myotome [10]. Among PMNs, they
show the largest and most extensive branching pattern [5]. MiPs
sprout a collateral axon to innervate dorsal myotome, while the
first ventral process extending along the common pathway is
retracted by 48 hpf [7]. RoPs innervate the middle region of the
muscle segment, sprouting laterally after pausing at the myosep-
tum [6]. Therefore, muscle pioneers represent a choice point from
which motoneurons select their specific pathway, although the
ablation of this cell population leads to abnormal motor axonal
extension without altering the target choice [7]. Secondary
motoneurons (SMNs) growth cones extend later from spinal cord,
beginning at 22 hpf and following the paths pioneered by the
primary axons [11,12].
Axonal pathfinding is dependent on attractive and repulsive
stimuli coming from both nervous and non-nervous surrounding
tissues [1,13]. For instance, shh induction by notochord and
floorplate patterns both primary and secondary motoneurons [14].
Indeed, mutants lacking both the notochord and the floorplate
(cyc2;flh2) [14] or mutants in the Hedgehog pathway, such as
smoothened (smo), present disorganized, reduced or absent PMNs
and axons. [15]. Moreover, in sonic-you mutants (syu) CaPs and
MiPs axons run along the neural tube horizontally instead of
ventrally and dorsally, while axons of the secondary motoneurons
fail to branch and instead cease to extend or grow further ventrally
in an abnormal pattern [16].
Also muscular tissues can pattern axonal migration: muscular
adaxial cells are able to rescue motor axon defects in diwanka
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mutants, showing that this myotomal population plays a pivotal
role in axonal migration [17]. Furthermore, molecules expressed
in the somites such as the semaphorin proteins Z1b and Sema3A1
are involved in repelling axonal migration [10,18]. On the
contrary, netrin-1a is expressed by adaxial cells and muscle pioneers
besides ventral spinal cord, and seems to guide axonal growth
through a chemoattractive function [19]. The manipulation of the
proper expression of these molecules, both knocking-down and
inducing ectopic expression, induces axons to follow aberrant
pathways, branch excessively or stall [17,18,19].
The Coiled-Coil-Domain Containing 80 (Ccdc80) gene, also named
DRO1 in human (Down-Regulated by Oncogene 1), URB in mouse (Up-
Regulated in BRS-3 deficient mice), CL2 in rat (Clone 2), and equarin in
chicken, has been recently suggested to be involved in different
functions among vertebrates. Ccdc80 was first isolated in mice,
where it is up-regulated in adipose tissue of obese BRS-3-deficient
animals [20]. Moreover, Ccdc80 is highly expressed in mice white
adipose tissue and its silencing inhibits adipocytes differentiation
[21], suggesting a role in the regulation of body weight and energy
metabolism. Ccdc80 is also expressed in mouse developing
cartilage, suggesting a role during skeletogenesis [22]
Human CCDC80 is almost ubiquitously expressed, with the
highest levels in heart and skeletal muscles [23,24]. Furthermore,
human CCDC80 can be considered a potential tumor suppressor
gene [25]. In fact, it is strikingly down-regulated in thyroid
neoplastic cell lines and tissues, as well as in colon and pancreatic
cancer cell lines and in most colorectal cancer specimens [26],
while its ectopic expression in these cell lines results in substantial
inhibition of growth properties.
The CCDC80 protein is highly conserved among vertebrates,
and contains multiple signals of cellular compartmentalization and
post-translational modifications. In particular, it has a N-terminus
leader peptide for extracellular export and many nuclear
localization signals [25]. In different studies, the CCDC80 protein
has been identified in a N-glycosylated form and was suggested to
be secreted. Rat, mouse and human CCDC80 show three P-
DUDES domains (Procaryotes- DRO1-URB-DRS-Equarin-SRPUL)
which in human are correlated with a tumor suppressor role [27].
In silico analysis using human CCDC80 sequence as a bait, led
to the identification of three zebrafish homologs of CCDC80. Two
homologs, that we named Ccdc80 and Ccdc80-like1 (Ccdc80-l1),
showed high levels of aminoacid identity with the human
CCDC80. We performed the molecular cloning of ccdc80 and
ccdc80-l1 in zebrafish and analyzed their expression pattern during
embryonic development. During somitogenesis ccdc80 is expressed
in the notochord (manuscript in preparation), while ccdc80-l1 is
expressed in muscle pioneers and adaxial cells. Both these regions
are responsible for axon guidance, therefore we decided to
investigate the role of ccdc80 and ccdc80-l1 in this process. While
loss-of-ccdc80-function did not impair motoneurons development,
we demonstrated the ccdc80-l1 involvement in the proper axonal
pathfinding, especially in ventral axons guidance. Indeed, ccdc80-l1
knocked-down embryos exhibited motility issues although analysis
on body musculature showed that somitogenesis and myogenesis
occurred properly. Furthermore, the analysis of ccdc80-l1 up-
stream regulation revealed that the Hedgehog pathway modulates
its expression in territories involved in axonal guidance.
Materials and Methods
Zebrafish lines and maintenance
Current italian national rules: no approval needs to be given for
research on zebrafish embryos. Zebrafish were raised and
maintained according to established techniques [28], approved by
the veterinarian (OVSAC) and the animal use committee (IACUC)
at the University of Oregon, in agreement with local and national
sanitary regulations. Embryos were collected by natural spawning,
staged according to Kimmel [29], and raised at 28uC in fish water
(Instant Ocean, 0.1% methylene blue) in Petri dishes [30].
Sequence analysis
Zebrafish chromosome 6 region hosting the ccdc80-l1 gene was
identified through in silico search of the ENSEMBL zebrafish
assembly version 9 (Zv9) using human CCDC80 aminoacidic
sequence as a bait. The alignments between aminoacid sequences
were performed with the software program StrecherP. Analysis on
synteny was performed with the program Genomicus version 57.01.
RT-PCR
Total RNA from 11 samples (an average of 30 embryos per
sample) corresponding to 9 different developmental stage embryos
(2–4 cells, 64–1000 cells, 30% epiboly, 60%–70% epiboly,
somitogenesis, 24 hpf and 72 hpf) and 2 adult organs (ovary and
muscle) was extracted with the TOTALLY RNA isolation kit
(Ambion), treated with RQ1 RNase-Free DNase (Promega) and
oligo (dT)-reverse transcribed using Super- Script II RT (Invitro-
gen), according to manufacturers’ instructions. The following
primers were used for PCR reactions: ccdc80-l1_forward 59-
ACCACAATGGAGCAAACACA -39 and ccdc80-l1_reverse 59-
GGTTTAGCTCTCCCCTTTGG -39. PCR products were
loaded and resolved onto 2% agarose gels.
In situ hybridization and immunohistochemistry
Whole-mount in situ hybridization (WISH), was carried out as
described [31] on embryos fixed for 2 hours in 4% paraformalde-
hyde in PBS, then rinsed with PBS-Tween (PBT), dehydrated in
100% methanol and stored at 220uC until processed [32].
Antisense riboprobes were previously in vitro labelled with modified
nucleotides (digoxigenin, Roche). myod and myog probes were
prepared as described by Schnapp and collegues [33]. smyhc1 probe
has been kindly provided by Ingham laboratory. The following
primers were used for PCR reactions to clone the probes: ccdc80-l1
sense 59- ACCACAATGGAGCAAACACA -39 and ccdc80-l1
antisense 59- GGTTTAGCTCTCCCCTTTGG -39. For immu-
nohistochemistry, embryos were fixed in 4% paraformaldehyde
overnight at 4uC or 2 hours at RT, washed several times in PBT
and blocked in 5% BSA in PBT for 1 hour at room temperature.
Primary antibody incubation was done overnight at 4uC, followed
by several washes in PBT and incubation of secondary antibody for
1 hour at room temperature. Primary antibodies are MF20 (mouse
anti-sarcomeric) and 4D9 (mouse anti-engrailed/invected) pur-
chased fromDevelopmental Studies Hybridoma Bank, znp1 (mouse
anti-syt2b) and zn-5 (mouse anti-alcama) purchased from Zebrafish
International Resource Center (ZIRC). Secondary antibody is
EnVision+ System- HRP Labelled Polymer anti-mouse (Dako).
Images of embryos and sections were acquired using a microscope
equipped with a digital camera with LAS Leica imaging software
(Leica, Wetzlar, Germany). Images were processed using the Adobe
Photoshop software. For histological sections, stained embryos were
re-fixed in 4% paraformaldehyde, dehydrated and stored in
methanol, wax embedded, and sectioned (5–8 mm).
Injections
Injections were carried out on 1- to 2-cell-stage embryos (with
Eppendorf FemtoJet Micromanipulator 5171); the dye tracer
rhodamine dextran was co-injected as a control. To repress ccdc80-
l1 mRNA translation we designed an ATG-targeting morpholino,
ccdc80-l1 and Axon Pathfinding in Zebrafish
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ccdc80-l1-MO: 59- TTGTACCTGTAGATTTTTCATTGCA-39
and a splice-site morpholino, ccdc80-l1-splice- 59- TGATACAATA-
CATACTATGAGGCGT -39 (Gene Tools, LLC). As a negative
control we injected a standard control morpholino oligonucleotide
(ctrl-MO). Morpholinos were injected in 16Danieau buffer (pH 7.6)
as suggested by Nasevicius and Ekker [34]. For the in vivo test of the
efficiency of ccdc80-l1-MO, 425 pg/embryo of the pCS2+-ccdc80-l1-
GFP sensor plasmid have been injected alone or co-injected with
12 ng/embryo of ccdc80-l1-MO. The presence/absence of the GFP
signal has been monitored under a fluorescent microscope starting
from somitogenesis up to 48 hpf. ccdc80-l1-MO cDNA fragments
inserted in the BamHI site were obtained using the following
complementary oligos: ccdc80-l1-MO sense 59- gatcTTGTACCTG-
TAGATTTTTCATTGCACA -39 and ccdc80-l1-MO antisense 59 –
gatcTGTGCAATGAAAAATCTACAGGTACAA- 39.
For the in vivo test of the specificity of morpholino-mediated
knockdown, the rescue of morphants phenotype was obtained co-
injecting 12 ng/embryo of ccdc80-l1-MO together with 400 pg/
embryo of ccdc80-encoding mRNA.
Over-expression of shh was obtained microinjecting 300 pg/
embryo of shh mRNA, kindly provided by Sordino laboratory.
Statistical analysis
Statistical analysis was performed with Student’s t-test using
GraphPad PRISM version 5.0 (GraphPad, San Diego, California).
A p value ,0.001 indicates a statistically significant effect.
Cyclopamine treatment
Embryos were exposed to 5 mM cyclopamine (purchased from
SIGMA-ALDRICH) from 50% epiboly stage up to fixation in
PFA at 15 somites stage. Cyclopamine was dissolved in embryo
medium and 0.5% ethanol. Controls consisted of corresponding
incubations in 0.05% ethanol in embryo medium.
Results
Identification of Ccdc80 homologs in the genome of
zebrafish
Blast analysis of the ENSEMBL zebrafish assembly version 9
(Zv9) using human CCDC80 as a bait returned three positive hits,
corresponding to three proteins encoded by genes on different
chromosomes: the first on chromosome 9 (nucleotide position:
35,060,460-35,084,513) that we named ccdc80, the second on
chromosome 6 (nucleotide position: 16,322,724-16,342,517) that
we named ccdc80-like1 (ccdc80-l1), and the third on chromosome 21
(nucleotide position: 18,662,129-18,669,986), that we named
ccdc80-like2 (ccdc80-l2). The alignment of the predicted protein
sequences in zebrafish with the human CCDC80, revealed that
Ccdc80 presented the highest degree of aminoacid identity with
human CCDC80 (51.6%), while Ccdc80-l1 and Ccdc80-l2
presented less identity (44.4% and 27% respectively) (Table 1
and Fig. S1). We then performed alignments among the three
zebrafish homologs: Ccdc80 shared the 51.4% of aminoacid
identity with Ccdc80-l1 and the 30.4% with Ccdc80-l2 while
Ccdc80-l1 and Ccdc80-l2 shared the 29.1% of identity (Table 1).
Moreover, analysis of chromosomal organization of the three
ccdc80 zebrafish homologs across vertebrates revealed that only
ccdc80 is synthenic with other vertebrates (Fig. 1).
ccdc80-l1 is expressed in muscle pioneers and adaxial
cells of the zebrafish embryo
Characterization of ccdc80-l1 expression, using RT-PCR,
revealed that ccdc80-l1 transcript is present from the first stages
of development up to 72 hpf, thus including maternal and zygotic
transcription (Fig. 2A). ccdc80-l1 is also expressed in the ovary and
muscle of the adult zebrafish (Fig. 2A). During somitogenesis, the
hybridization signal is restricted to the horizontal myoseptum
(Fig. 2B–D). From this stage, ccdc80-l1 expression is observed also
in the cranial ganglia and dorsal dermis (Fig. 2B, 2C, 2E, 2I, 2K–L
and data not shown). At 24 hpf, ccdc80-l1 is detectable in a specific
sub-population of migrating adaxial cells, that moves along the
lateral axis towards the external somite [35] (Fig. 2E–G).
Moreover, ccdc80-l1 is expressed in muscle pioneers, as shown by
the co-localization between ccdc80-l1 and engrailed [36,37]
(Fig. 2H). ccdc80-l1 expression in adaxial cells persisted at 36 hpf
and 48 hpf (Fig. 2I, 2K). At the same stages ccdc80-l1 is also
expressed in the caudal vein plexus region (Fig. 2I, 2J, 2L).
ccdc80-l1 knocked-down embryos displayed impaired
motility
To determine the functional role of ccdc80-l1 during zebrafish
development, we specifically knocked it down by means of the
injection of an antisense oligonucleotide morpholino (ccdc80-l1-MO,
Gene Tools) designed against the start site of the transcript. In all the
experiments, ccdc80-l1-MO-injected embryos (morphants) were
compared to embryos at the same developmental stage, injected
with the same amount of a control MO (ctrl-MO). For the in vivo test
of the efficiency of ccdc80-l1-MO, 425 pg/embryo of the pCS2+-
ccdc80-l1-GFP sensor plasmid has been injected alone or with
12 ng/embryo of ccdc80-l1-MO. The presence/absence of the GFP
signal has been monitored under a fluorescent microscope starting
from somitogenesis up to 48 hpf (Fig. S2). 70% of the embryos
(N=20) injected with the sensor plasmid alone displayed fluores-
cence. This percentage decreased to 51% when the plasmid was co-
injected with ccdc80-l1-MO (N=93), indicating that the morpholino
specifically bound to its target region. The efficiency of ccdc80-l1
Table 1. Percentages of identity and similarity among human and zebrafish Ccdc80 homologs.
Human CCDC80 Zebrafish Ccdc80 Zebrafish Ccdc80-like1 Zebrafish Ccdc80-like2
Identity Similarity Identity Similarity Identity Similarity Identity Similarity
Zebrafish Ccdc80 51,6% 65,2% / / 51,4% 64,4% 30,4% 47,4%
Zebrafish Ccdc80-
like1
44,4% 59,3% 51,4% 64,4% / / 29,1% 46,9%
Zebrafish Ccdc80-
like2
27% 44,9% 30,4% 47,4% 29,1% 46,9% / /
The table shows the scores obtained after alignments between the aminoacidic sequences of zebrafish and human CCDC80 homologs. Alignments were performed
with Stretcher-P tool.
doi:10.1371/journal.pone.0031851.t001
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loss-of-function was not so striking, as demonstated by the low
percentage of embryos with GFP decreasement and by the high
amount of morpholino we had to inject to obtain a phenotype (8
and 12 ng/embryo of ccdc80-l1-MO). Therefore, we designed a
second morpholino against the splice site (ccdc80-l1-splice-MO) to
confirm the specificity of ccdc80-l1-loss-of-function. Embryos
injected with this second morpholino, still exhibited motility issues
as ccdc80-l1-MO-injected embryos did (data not shown). In
particular, all the knocked-down embryos showed no severe body
plan alteration when observed in vivo, indicating the proper
Figure 2. Expression of ccdc80-l1 analyzed by RT-PCR and WISH. (A) RT-PCR performed on different embryonic stages and adult tissues; the
expression of ccdc80-l1 and b-actin are shown. Lanes are: ladder (lane 1), ovary (lane 2), 2–4 cells stage (lane 3), 64–1000 cells stage (lane 4), 30%
epiboly (lane 5), 60–70% epiboly (lane 6), somitogenesis (lane 7), 24 hpf (lane 8), 30 hpf (lane 9), 48 hpf (lane 10), 72 hpf (lane 11), adult muscle (lane
12) and negative control (lane 13) in the absence of cDNA. (B–J) WISH performed on zebrafish embryos at several stage of development. (B, C) During
somitogenesis ccdc80-l1 was expressed by cranial ganglia (cg), dorsal dermis (asterisk), adaxial cells and muscle pioneers at the level of the horizontal
myoseptum (arrow). (D) ccdc80-l1 expression in a transverse section of the trunk of an embryo at 12 somites stage (arrows). (E–H) At 24 hpf, the
hybridization signal was detectable in cranial ganglia (cg), dermis (asterisk), adaxial cells (arrow) and ventral somites (arrowhead). (F) Higher
magnification of the tail at 24 hpf. (G) Transversal section of an embryo at 24 hpf. (H) Transversal section showing that at 24 hpf ccdc80-l1
hydridization signal co-localized with the nuclear labeling of 4D9 antibody, corresponding to the engrailed-positive muscle pioneers population
(open arrowhead). (I, J) At 36 hpf, the signal of ccdc80-l1 probe was detected in cranial ganglia (cg), migrated adaxial cells (arrow), dorsal dermis
(asterisk) and caudal vein plexus region (cvp). (K, L) At 48 hpf, ccdc80-l1 was detected in dorsal dermis (asterisk), external adaxial cells (arrows in K) and
caudal vein plexus region (cvp in L). (B, E, F, I) Lateral views; dorsal is up, anterior is left; (C) dorsal view, anterior is left; (D,G, H, J–L) transversal sections,
dorsal is up.
doi:10.1371/journal.pone.0031851.g002
Figure 1. Analysis of chromosomal organization of the three ccdc80 zebrafish homologs across vertebrates. Each ccdc80 gene is shown
as a reference locus. Genes annotated as paralogs (no surrounding line) or orthologs (with a surrounding line) by the Ensembl database share the
same color, blue lines beneath individual tracks indicate that orientations of gene blocks and are inverted with respect to their genomic annotation.
For zebrafish ccdc80 (chr. 9), ccdc80-l1 (chr. 6) and ccdc80-l2 (chr. 21), only ccdc80 shows notable synteny with other vertebrates. The figure was
derived from the output of the Genomicus website (version 57.01).
doi:10.1371/journal.pone.0031851.g001
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progression of early developmental processes such as gastrulation
and segmentation [38,39,40,41]. Moreover, we observed that
morphants displayed physiological body contractions upon dechor-
ionation at 24 hpf [42]. However, at 48 hpf, almost 80% of the
morphant embryos (N=37) presented abnormal escaping behavior
after tactile stimulation, often resulting in body contractions on the
spot or circling behavior (Video S2) rather than a fast escape in the
opposite direction to the stimulus (Video S1). The same phenotype
was observed also at 5 days post fertilization (5 dpf, data not shown).
These results indicated that ccdc80-l1 loss-of-function affects the
swimming behavior of zebrafish embryos and larvae. We were also
able to rescue the ccdc80-l1-loss-of-function phenotype by means of
the injection of the homolog ccdc80-full-length transcript. In fact,
despite we demonstrated that ccdc80-loss-of-function did not affect
axonal pathfinding (data not shown), the high degree of conserva-
tion between the two homologs allowed rescue of motility (only 42%
of rescued embryos presented motility issues in comparison to the
nearly 80% of ccdc80-l1-MO injected embryos, N=63).
ccdc80-l1 loss of function does not affect somitogenesis
nor muscle pioneers and adaxial cells formation
To assess whether the phenotype displayed by morphants was
due to the impairment of musculature, we examined somitogenesis
and myogenesis markers. The expression of myod and myog [39,43]
was not altered in ccdc80-l1-MO-injected embryos (Fig. 3A–D).
Moreover, the expression of smyhc1, a marker of slow-twitch fibers
[44], was unaffected as well, notwithstanding the strong expression
of ccdc80-l1 in adaxial cells and muscle pioneers, from which slow
fibers develop [9] (Fig. S3A, S3B). In addition, at 24 hpf,
myofibers were correctly organized and distributed as shown by
the immunohistochemistry with anti-sarcomeric MF20 antibody
[45] (Fig. 3E, 3F). Also muscle pioneers, labeled with 4D9 anti-
engrailed antibody [36,37] were correctly formed in ccdc80-l1
morphants (Fig. 3G–H). These results led us to exclude that defects
of adaxial cells, muscle pioneers or body musculature formation
were responsible for motility issues observed in ccdc80-l1 knocked-
down embryos.
Figure 3. Analysis of myogenic markers expression and muscle pioneers in ccdc80-l1 morphant embryos. (A–D) The myogenic markers
myod (A, B) and myog (C, D) were correctly expressed both in control and morphants embryos at 10 s stage (A, B) and 24 hpf (C, D), respectively. (E, F)
The MF20 antibody staining showed that both slow and fast twitch fibers were correctly formed and distributed in control and in knocked-down
embryos at 24 hpf. (G, H) At the same developmental stage, muscle pioneers resulted unaffected after ccdc80-l1 loss-of-function, as shown by the
labeling with 4D9 antibody (anti-engrailed) (arrows). (A, B) Dorsal views, anterior is left; (C–H) lateral views of the tails, dorsal is up and anterior is left.
doi:10.1371/journal.pone.0031851.g003
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Proper pathfinding and branching of axons are affected
in ccdc80-l1-MO-injected embryos
Segmentally repeated motoneurons connect nervous system to
somites, as their growth cones exit the spinal cord during
embryogenesis and migrate to their appropriate muscle targets,
allowing movement [3,5]. Due to motility impairment of ccdc80-l1
morphants, we investigated the morphology of motoneurons
performing immunohistochemistry with znp1 (syt2b) antibody [46].
For all embryos, we analyzed the trunk region overhanging the
yolk extension; defects in at least three motoneurons were enough
to consider the embryo as affected. At 48 hpf, in the 84% (N=33)
of morphants injected with 12 ng/embryo of morpholino, axonal
pathfinding resulted impaired. 60% of morphants displayed an
overall disorganization of both dorsal and ventral motoneurons,
that resulted mis-orientated and over-branched (Fig. 4A, 4B). In
the 9% of embryos, these defects were observed together with an
opposite phenomenon, axonal stalling. In the 12% of morphants
only ventral axons resulted mis-orientated and over-branched,
whereas in the 3% only the dorsal ones were affected. This
phenotype was dose-dependent: when 8 ng/embryo of morpho-
lino were used, a lower percentage of embryos resulted affected
(64%, N=35). Interestingly, at this concentration, only 27% of the
knocked-down embryos displayed both ventral and dorsal
defective axons, whereas in the 37% of morphants the same
defects were detectable in the ventral motoneurons solely (Fig. 4C).
Dorsal axons alone were never affected (Table 2 and Fig. S4).
Thus, a striking reduction of Ccdc80-l1 protein amount led to the
affection of both ventral and dorsal motoneurons, whereas a lower
dose of morpholino is sufficient for ventral axons migration
impairment. In order to discriminate whereas loss-of-ccdc80-l1-
Figure 4. Analysis of motoneurons morphology by means of znp1- and zn-5-immunohistochemistry. (A, B) At 48 hpf, using 12 ng/
embryo of morpholino, both ventral (arrows) and dorsal axons (arrowheads) were mis-orientated and over-branched in morphants (B) in comparison
to control embryos (A). (C) Statistical analysis showing the percentages of the different phenotypes (affected ventral axons, dorsal axons or both)
occurring in control embryos and in morphants, when different doses of ccdc80-l1-MO were injected (12 ng/embryo and 8 ng/embryo). Using a lower
dose of morpholino (8 ng/embryo), we observed that in a significant percentage of embryos only ventral axons were defective. (D–G)
Immunohistochemistry performed at 26 hpf (D, E) and 30 hpf (F, G) confirmed that loss-of-ccdc80-l1-function affects both CaPs (arrows) and MiPs
(arrowheads) axonal migration. (H, I) The same analysis performed at 48 hpf using zn-5 antibody revealed that also SMNs axonal migration is impaired
in morphants (arrows in I) in comparison to control embryos (H). (A, B; D–I) Lateral flat-mount preparation was applied for a better visualization of the
motoneurons. Lateral views of the trunk region overhanging the yolk extension, dorsal is up and anterior is left.
doi:10.1371/journal.pone.0031851.g004
Table 2. The phenotype of ccdc80-l1-MO-injected embryos is dose-dependent.
Dose/type of
morpholino
Total percentage of affected
embryos (N)






ctrl-MO 12 ng 12% (N= 25) 12% 0% 0%
ccdc80-l1-MO 12 ng 84% (N= 33) 69% 12% 3%
ccdc80-l1-MO 8 ng 64% (N= 35) 27% 37% 0%
The percentage of embryos displaying axonal defects decreased from 84% to 64% when a lower dose of morpholino was used. Both ventral and dorsal axonal
pathfinding resulted impaired in the 69% of affected embryos when 12 ng/embryo of morpholino were used. After the injection of the lower dose of ccdc80-l1-MO
(8 ng/embryo), 27% of affected embryos showed alteration of both ventral and dorsal axons, whereas the 37% displayed only ventral defective axons and dorsal axons
alone were never affected.
doi:10.1371/journal.pone.0031851.t002
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function impaired PMNs or SMNs, we analyzed the phenotype of
morphants also at 26 hpf and 30 hpf, by the time SMNs have just
begun extending axons [47], so most of znp1 labeling correspond
to PMNs. At this stages, we replicated the same phenotype
observed at 48 hpf (Fig. 4D–G and Table 3). Furthermore, by
performing an immunohistochemistry at 48 hpf using the specific
antibody for SMNs (zn-5, anti-alcama) [47], we observed that also
SMNs axons seems to be affected after loss-of-ccdc80-l1-function
(Fig. 4H, 4I). Thus, the analysis of the motoneuronal patterning in
morphant embryos revealed the lack of proper guidance toward
muscle targets, suggesting ccdc80-l1 involvement in axonal
pathfinding of both PMNs and SMNs.
ccdc80-l1 expression is positively regulated by the
Hedgehog pathway
Both muscle and motoneurons induction is finely regulated by
levels and range of shh expression [9,48,49]. Due to ccdc80-l1
expression in adaxial cells and muscle pioneers, we decided to
investigate the existence of a ccdc80-l1 up-stream regulation
Hedgehog-mediated. We modulated shh activity by exposing
embryos to cyclopamine, that inhibits the Hedgehog transducer
Smoothened (smo) [9,50]. To avoid the complete loss of the
territories in which ccdc80-l1 is expressed, we chose a concentra-
tion of cyclopamine (5 mM) by which muscle pioneers and adaxial
cells-derived slow fibers are unaffected, as already described [9]
and as we demonstrated by the proper expression of their markers
engrailed, myod and smyhc1 respectively. (Fig. S5). A striking down-
regulation of ccdc80-l1 expression was observed in 72% of the
treated embryos in comparison to controls (N= 32) (Fig. 5A, 5B).
Interestingly, this down-regulation was detectable only at the level
of myoseptum and somites, whereas the cephalic territories in
which ccdc80-l1 is expressed were not involved. A similar down-
regulation was observed in syu mutants, carriers of a deletion in the
gene sonic-you encoding for shh (Fig. 5D–F) [16]. ccdc80-l1 signal in
adaxial cells was extremely weak or absent in the 35% of mutants,
and slightly down-regulated in the 40% of observed embryos
(N= 20). Moreover, the overexpression of shh by means of the
injection of the full-length transcript (300 pg/embryo), led to the
opposite phenotype with an increasing of ccdc80-l1 expression in
the somites of the 71% of the injected embryos (N=31) (Fig. 5C).
On the contrary, ccdc80-l1 loss-of-function did not affect shh
expression (Fig. S6). Therefore, these findings suggest that ccdc80-
l1 is a down-stream target of the Hedgehog pathway.
Discussion
The genetic program underlying axon guidance is not
completely defined. Adaxial cells and muscle pioneers are both
involved in axonal outgrowth and pathfinding [7,17], even if little
is known about the specific proteins and molecular mechanisms
acting in this process. ccdc80-l1, the novel gene we recently
identified in zebrafish, is expressed during embryonic development
in muscle pioneers and adaxial cells. Ccdc80-l1 was identified,
together with its homolog Ccdc80, on the basis of its high
aminoacid identity with human CCDC80. However, zebrafish
ccdc80 and ccdc80-l1 do not share the same expression pattern and
seems to play different roles. In fact, only ccdc80-l1-MO-injected






CaPs and MiPs Only CaPs affected Only MiPs affected
26 hpf/ccdc80-l1-MO 12 ng 54,5% (N= 33) 40% 11% 3,5%
30 hpf/ccdc80-l1-MO 12 ng 62% (N=35) 33% 24,5% 4,5%
Embryos injected with 12 ng/embryo of ccdc80-l1-MO were observed also at 26 hpf and 30 hpf. At these stages, affected embryos were 54,5% and 62%, respectively.
The percentages of the different phenotypes are listed.
doi:10.1371/journal.pone.0031851.t003
Figure 5. ccdc80-l1 is positively regulated by shh. (A–C) ccdc80-l1 expression in somites and myoseptum resulted strongly inhibited in embryos
treated with 5 mM cyclopamine (asterisks in B), in comparison to control embryos at the same developmental stage (A). By converse, over-expression
of shh led to an up-regulation of ccdc80-l1 in muscular territories (C). Expression in cranial ganglia (cg) was never perturbed. (D–F) ccdc80-l1 resulted
slightly down-regulated in the muscles of heterozygous syu+/2 mutants (E) in comparison to wild type siblings (D). A strikingly down-regulation was
observed in homozygous syu2/2 mutants (F). (A–C) Dorsal flat-mount preparations, anterior is up. (D–F) Lateral views of the tails, anterior is left.
doi:10.1371/journal.pone.0031851.g005
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embryos displayed an abnormal escaping behavior after tactile
stimulation at 48 hpf. Both musculature and nervous system are
responsible for embryonic motility and touch response and are the
basis of spontaneous motor output that occurs in the developing
zebrafish embryo ever since 18 hpf [2]. Nevertheless, musculature
defects were unlikely the basis of the observed phenotype. Indeed,
there was no difference between the expression pattern of
myogenic markers in morphants and control embryos. Moreover,
muscle fibers resulted correctly formed and distributed by the end
of somitogenesis. The territories in which ccdc80-l1 is expressed
were unaffected as well: in fact, adaxial cells and muscle pioneers
showed no defects. These findings revealed that ccdc80-l1 function
is not necessary for the specification and further differentiation of
myogenic cell populations, suggesting that the motility issues
displayed by morphants at 48 hpf could be due to an impairment
of neuronal development.
The analysis of motoneuronal development in morphant
embryos revealed that ccdc80-l1 plays a role in motoneurons
axonal pathfinding. In fact, ccdc80-l1 loss-of-function did not
prevent the formation of PMNs and axon projection, but led to an
overall disorganization of PMNs. CaPs and MiPs resulted over-
branched in a high percentage of embryos, whereas a smaller
fraction of morphants displayed also the simultaneous presence of
its opposite phenomenon, axonal stalling. Axonal over-branching
and stalling were detected in the CaPs solely in a significant
percentage of embryos, especially when a lower dose of
morpholino was used. Moreover, the impairment of axonal
migration was more severe in CaPs then in MiPs, even when
both PMNs were affected simultaneously. These data suggest that
ccdc80-l1 may have a differential role as regards the development
of CaPs and MiPs. This is consistent with the asymmetric
distribution of ccdc80-l1 transcript in the somites: indeed, the
ccdc80-l1 transcript is present in the ventral portion of somites,
innervated by CaPs, and not in their dorsal portion, innervated by
MiPs. The same motility issues displayed at 48 hpf were observed
also at 5 dpf, when secondary motoneurons are already formed.
Therefore, ccdc80-l1 plays a role also in guidance of SMNs, as
shown by the mis-expression of their marker zn-5. This is not
surprising, as the growth cones of SMNs require the axons of
PMNs for proper pathfinding [6]. We concluded that the ccdc80-l1
loss-of-function prevents the proper development of the peripheral
nervous system, that lacks a proper guidance toward muscle target:
axons do not fallow a single direction-pathway but stall or extend
towards any direction, leading to an over-branched and non-
functional nervous network. Hence, embryos are able to move and
to respond to tactile stimuli, but the coordination of muscle
contractions is impaired, and motor behavior is affected.
Axon outgrowth is influenced by many factors, for instance
different molecules (netrins, semaphorins, slits) with chemotropic
functions (reviewed in [51]) and components of the extracellular
matrix (ECM) [52,53]. In fact, the growth cone shares many
features with the motile structures of migrating cells, including
actin polymerization at the leading edge, dynamic interactions
between cell-surface adhesion receptors and components of the
extracellular matrix (ECM), and generation of traction forces in
the cytoskeleton applied to ECM through adhesion sites [54,55].
In ccdc80-l1 knocked-down embryos, the growth cones are still able
to exit the spinal cord and reach the muscle pioneers along the
common pathway. Moreover, axonal extensions developed
without altering the target choice: in fact, CaPs and MiPs still
project their axons ventrally and dorsally, respectively. These data
are consistent with the proper development of muscle pioneers,
which provide a choice point for motor growth cones. However,
further defects occur during axon pathfinding. It has been recently
reported that DRO1/CCDC80 is a Golgi-associated-protein [56].
Moreover, the in silico prediction of the Ccdc80 protein structure
(String 9.0) suggests its interaction with fibronectin, a component
of the ECM. If this is the case also for its homolog ccdc80-l1, its
loss-of-function might interfere with the proper axon migration by
influencing the secretion of guidance molecules or by altering
interactions with ECM proteins such as fibronectin. Further
analysis on the predicted Ccdc80-l1 protein sequence and its
interaction with other proteins will be necessary to understand the
molecular process underlying ccdc80-l1 functioning. Moreover,
investigation on possible targets is still needed. For instance, it is to
explore the possibility of an interaction with the semaphorin and
netrin families, both involved in attracting and/or repelling
growth cones from a variety of organisms [13,19]. Nevertheless,
our results provide further insights into motoneurons develop-
ment, a complex mechanism that requires the action of several
different molecules. Moreover, we suggest that ccdc80-l1may act as
a down-stream effector of shh. The Hedgehog family consists of
secreted morphogens fundamental for both axon guidance and
formation of adaxial cells and muscle pioneers [9,57]. The
Hedgehog signaling is known to play a pivotal role in the
specification of both primary and secondary motoneurons [14,49].
Indeed, mutants for different molecules involved in this pathway
displayed axonal defects, including random axonal migration or
stalling [15,16]. PMNs target choice was never impaired after
ccdc80-l1 loss-of-function, still axonal migration resulted aberrant.
Furthermore, ccdc80-l1 expression resulted strikingly down-regu-
lated after exposure to 5 mM of cyclopamine and up-regulated
after over-expression of shh. This modulation was observed only in
muscles and not in other territories in which s-ccc80 is expressed
(cranial ganglia and dorsal dermis). These findings strongly suggest
the existence of a specific regulation Hedgehog-mediated of
ccdc80-l1, as regards its function in motoneuronal development.
Moreover, these findings may shed light on the involvement of the
Hedgehog pathway in this process.
Supporting Information
Figure S1 Alignment among human CCDC80 and the
three zebrafish homologs. * = identical aminoacids; : = con-
servative substitution; . = non-conservative substitution.
(TIF)
Figure S2 ccdc80-l1morpholino is capable to inhibit the
expression of the fluorescent protein GFP. This assay was
performed in order to verify the in vivo efficiency of ccdc80-l1-MO.
(A, B) In the 70% of embryos injected with the ccdc80-l1-GFP
sensor plasmid, the presence of fluorescent GFP signal was
detected (N= 20). (C, D) When the plasmid was injected together
with the morpholino, the transcription of GFP protein was
inhibited and the percentage of fluorescent embryos decreased to
51% (N=93). In A and C embryos are visualized under normal
light, in B and D under fluorescent light.
(TIF)
Figure S3 The expression pattern of the slow-myosin
marker smyhc1 is unaffected in ccdc80-l1 knocked-down
embryos. (A, B) Loss-of-ccdc80-l1-function did not perturb the
expression of smyhc1, as morphant embryos (B) are indistinguish-
able from control embryos (A). Lateral views of the tails, dorsal is
up, anterior is left.
(TIF)
Figure S4 Statistical analysis of three distinct defects
observed after loss-of-ccdc80-l1-function. (A–C) The
graphics show the occurrence of three axonal migration defects
ccdc80-l1 and Axon Pathfinding in Zebrafish
PLoS ONE | www.plosone.org 8 February 2012 | Volume 7 | Issue 2 | e31851
in control embryos and morphants when two doses of ccdc80-l1-
MO are used: both dorsal and ventral defective axons (A), only
ventral defective axons (B) and only dorsal defective axons (C).
The last phenotype was not statistically significant. *** p,0.001 vs
ctrl-MO. * p,0.05 vs ctrl-MO.
(TIF)
Figure S5 Muscle pioneers and adaxial cells are present
after 5 mM cyclopamine treatment. (A, B) Labeling with 4D9
antibody (anti-engrailed) showed that muscle pioneers are not
missing after pharmacological inhibition of the Hedgehog pathway
(arrows). (C–F) Also adaxial cells are still present, as shown by the
expression of the markers myod (C, D) and smyhc1 (E, F). (A, B)
Lateral views, dorsal is up. (C–F) Dorsal views, anterior is left.
(TIF)
Figure S6 shh expression is not perturbed by loss-of-
ccdc80-l1-function. (A, B) shh resulted correctly expressed both
in control embryos (A) and in morphants (B). (A, B) Dorsal views,
anterior is left.
(TIF)
Video S1 Control embryos displayed standard motor
behavior. After tactile stimulation, control embryos fast escaped
in the opposite direction of the stimulus.
(AVI)
Video S2 The motility of morphant embryos is im-
paired. When morphants were stimulated, abnormal escape was
observed, also resulting in circling behavior.
(AVI)
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